What move does the options market price into CG Oncology's report?

Implied ±21.4%, either direction.

How often does CG Oncology move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

CGONNasdaqBiological Products, (No Diagnostic Substances)

CG Oncology, Inc. (CGON) earnings date, market-implied expected move, and options open interest by expiry

64.57

−3.14 · −4.64%

Regular session11:32 ET

Open68.00Volume1.4MMkt cap$6.0BEPS-2.70

Day64.57 – 68.000%52-wk35.80 – 80.9764%

CGON

CG Oncology, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±21.4%implied · report alone

8Q avg ±4.0%·×5.33·rich

53.2382.19

straddle ±25.2%

spot 67.71exp Nov 20ATM strike 70ATM straddle 20.05IV 175%

Nov 4 closereport share · term structure

Expected move

Inputs

Next report

Nov 13

before open · in 8 days

est.Q3 FY26

Calendar

Next report

Last report

+3.36%

vs ±14.5% implied · ×0.23

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

filed ties

13F top-10 QoQ

+8.83%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

233 managers

Top fund weight

1.20%

CGON weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

CG Oncology (CGON) is expected to report on Nov 13 before open (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±11.6%
avg realized: ±4.0%

Nov 12 '24Nov 12 '24confirmed±11.1%▼−6.83%×0.62

Mar 28 '25Mar 28 '25confirmed±14.0%▼−1.93%×0.14

May 13 '25May 13 '25confirmed±8.5%▼−3.90%×0.46

Aug 8 '25Aug 8 '25confirmed±13.8%▲+2.05%×0.15

Nov 14 '25Nov 14 '25confirmed±10.0%▲+8.61%×0.86

Q1 FY26Feb 27 '26confirmed±10.7%▲+4.79%×0.45

May 8 '26May 8 '26confirmed±9.9%▲+0.64%×0.06

Q2 FY26Aug 6 '26confirmed±14.5%▲+3.36%×0.23

quarterimplied−15%0+15%realized×

Q2 FY26±14.5%▲+3.36%×0.23

May '26±9.9%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 2 close

0.85OI · 4 expiries · Nov 2 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

6,723+10%Nov 2015d7,873+6%

1,204+28%Dec 1843d0.552,206+15%0.55

1,197+2%Jan 1571d0.0523,072+7%0.05

180+26%Apr 16162d0.41443+16%0.41

ExpiryPutsCallsP/C

Nov 2015d6,723+10%7,873+6%0.85

Dec 1843d1,204+28%2,206+15%0.55

Jan 1571d1,197+2%23,072+7%0.05

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±25.2%

Funds 4

XBI±0.3%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−6832.84%as filednet margin · revenue +6.83% QoQ

Revenue$1M+6.83%

Gross profit−$3M−239.24%−47.31%

Operating income−$86M−7467.68%−30.14%

Pre-tax income−$79M−31.32%

Net income−$79M−6832.84%−31.32%

Cost of revenue$4M+32.51%

Operating expenses$84M+29.64%

Other income$7M+18.72%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 11:30 ET

Intraday

Event sensitivity

NFP ×1.63· ±4.5% vs ±2.8% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±4.5%6 of 10×1.63

PPIproducer prices±3.2%6 of 10×1.15

FOMCrate decision±2.4%12 of 22×0.85

PCEpersonal income & outlays±2.1%9 of 19×0.75

GDPgross domestic product±1.8%11 of 19×0.66

CPIconsumer prices±1.7%4 of 10×0.61

CPROFcorporate profits±1.4%6 of 12×0.50

Bar = avg |move| to ±5% · tick = ±2.8% avg day · ×base = |move| ÷ ±2.8% · min 6 releases

Earnings history

EPS -0.90 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.90	—
Q1 FY26	Feb 27 '26 · confirmed	-0.71	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod